Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report

BACKGROUND: Molecular targeted therapies have dramatically improved the prognosis of metastatic renal cell carcinoma. However, patients in whom the treatment could initially be effective will experience disease progression later. CASE PRESENTATION: A 74-year-old Japanese man who was diagnosed with r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Med Case Rep
Autors principals: Ueda, Kosuke, Suekane, Shigetaka, Ogasawara, Naoyuki, Chikui, Katsuaki, Suyama, Shunsuke, Nakiri, Makoto, Nishihara, Kiyoaki, Matsuo, Mitsunori, Igawa, Tsukasa
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911686/
https://ncbi.nlm.nih.gov/pubmed/27312478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0961-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars